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High-Dose Adenosine Overcomes the Attenuation
of Myocardial Perfusion Reserve Caused by Caffeine
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London, United Kingdom
Objectives We studied whether an increase in adenosine dose overcomes caffeine antagonism on adenosine-mediated cor-
onary vasodilation.
Background Caffeine is a competitive antagonist at the adenosine receptors, but it is unclear whether caffeine in coffee al-
ters the actions of exogenous adenosine, and whether the antagonism can be surmounted by increasing the
adenosine dose.
Methods Myocardial perfusion scintigraphy (MPS) was used to assess adenosine-induced hyperemia in 30 patients before
(baseline) and after coffee ingestion (caffeine). At baseline, patients received 140 g/kg/min of adenosine com-
bined with low-level exercise. For the caffeine study, 12 patients received 140 g/kg/min of adenosine (stan-
dard) and 18 patients received 210 g/kg/min (high dose) after caffeine intake (200 mg). Myocardial perfusion
was assessed semiquantitatively and quantitatively, and perfusion defect was characterized according to the
presence of reversibility.
Results Caffeine reduced the magnitude of perfusion abnormality induced by standard adenosine as measured by the
summed difference score (SDS) (12.0  4.4 at baseline vs. 4.1  2.1 after caffeine, p  0.001) as well as de-
fect size (18% [3% to 38%] vs. 8% [0% to 22%], p  0.01), whereas it had no effect on the abnormalities
caused by high-dose adenosine (SDS, 7.7  4.0 at baseline vs. 7.8  4.2 after caffeine, p  0.7). There was
good agreement between baseline and caffeine studies for segmental defect category (kappa  0.72, 95% con-
fidence interval: 0.65 to 0.79) in the high-dose group. An increase in adenosine after caffeine intake was well
tolerated.
Conclusions Caffeine in coffee attenuates adenosine-induced coronary hyperemia and, consequently, the detection of perfu-
sion abnormality by adenosine MPS. This can be overcome by increasing the adenosine dose without compro-
mising test tolerability. (J Am Coll Cardiol 2008;52:2008–16) © 2008 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.08.052u
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Fdenosine is a potent coronary vasodilator that increases
yocardial blood flow up to 4-fold and provokes flow
eterogeneity and even ischemia in territories served by
tenosed epicardial coronary arteries (1). According to
xperimental data (2,3), methylxanthines can attenuate the
oronary hyperemic response to adenosine through the
lockade of arteriolar A2A adenosine receptors, thereby
otentially halting the detection of flow-limiting coronary
rtery disease (CAD) by adenosine myocardial perfusion
cintigraphy (MPS). A limited body of evidence indicates
hat caffeine, a 1,3,7-trimethylxanthine that binds to the
rom the *National Heart and Lung Institute, Imperial College London, United
ingdom; and the †Nuclear Medicine Department and ‡Clinical Biochemistry
epartment, Royal Brompton Hospital, London, United Kingdom.f
Manuscript received April 15, 2008; revised manuscript received July 21, 2008,
ccepted August 19, 2008.biquitous adenosine receptors in a competitive manner (4),
an abolish myocardial blood flow heterogeneity induced by
ipyridamole, a vasodilator agent that acts by augmenting
he concentration of endogenous adenosine (5,6). On this
asis, it might be expected that caffeine would also inhibit
yperemia by exogenous adenosine. However, recent studies
ave shown that caffeine does not modify the coronary
asodilator response to adenosine and have suggested that at
he doses given, adenosine results in greater concentrations
f adenosine molecules than dipyridamole to compete with
affeine for receptor occupancy (7,8). Other factors such as
ariations in study methodology, subject population, and
affeine dose could also account for these discrepant results.
The effect of caffeine on adenosine MPS remains unclear.
urthermore, adenosine stress testing is increasingly per-ormed with supplemental exercise yet the effect of caffeine on
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December 9, 2008:2008–16 High-Dose Adenosine Overcomes Caffeine Antagonismhis modality of stress is unknown. Because of the competitive
nteraction between adenosine and caffeine, receptor block-
de by caffeine could be surmounted by increasing the
denosine dose; however, the effectiveness of this measure
as not been examined. Thus, we hypothesized that caffeine
n coffee would reduce the magnitude of the reversibility of
perfusion abnormality demonstrated by adenosine MPS,
nd that an increase in adenosine would overcome caffeine
ntagonism and provoke the same perfusion abnormality in
he presence of caffeine compared with the abnormality
sing a standard protocol after caffeine abstention.
ethods
tudy design and subject selection. This was a prospec-
ive single-center study. Patients were eligible if they had
uspected or known CAD (i.e., previous myocardial infarc-
ion, revascularization, or documented angiographically sig-
ificant coronary artery stenosis) and were scheduled for
denosine MPS (baseline procedure) for the clinical assess-
ent of anginal symptoms. Patients were enrolled if they
ad refrained from caffeine-containing products for at least
2 h before stress testing and had unequivocal reversible
yocardial perfusion abnormality at baseline. Patients who
ulfilled the entry criteria returned for repeat adenosine
PS after caffeine intake. Exclusion criteria were as follows:
) contraindication to adenosine, intolerable symptoms, or
dverse reaction during baseline procedure; 2) left bundle
ranch block or paced rhythm on resting electrocardiogram;
) serum caffeine concentration 2 mg/l at baseline;
) reversibility involving 10% of total left ventricular
yocardium or, in other words, 2 of 17 myocardial
egments on baseline MPS; and 5) change in symptoms,
edication, or documented acute ischemic event or coro-
ary intervention between the 2 MPS procedures. A total of
0 patients were enrolled in the study. The Royal Brompton
nd Harefield Research Ethics Committee approved the
tudy, and written informed consent was obtained from all
atients.
tudy protocol. All patients made 2 visits. For each visit,
atients were asked to refrain from caffeinated products for
minimum of 12 h before the test. Medications were not
ltered. For the baseline procedure (visit 1), stress testing
as performed with adenosine infused at the standard dose
f 140 g/kg/min for 6 min combined with low-level
xercise on a bicycle ergometer. Patients unable to cycle
erformed isometric exercise with handgrip. A blood sample
as drawn immediately before the start of the adenosine
nfusion to measure caffeine concentration. Within 6 weeks
f the baseline procedure (visit 2), repeat stress testing was
erformed 60 min after ingestion of coffee to allow plasma
affeine level to reach its maximum (9). To determine the
ffect of caffeine on adenosine MPS, 12 patients received
denosine at 140 g/kg/min for 6 min combined with
xercise as for the baseline study (standard adenosine
roup). To demonstrate the efficacy of high-dose adenosine, t8 patients received 210 g/kg/
in of adenosine for 6 min with
upplemental exercise performed
n identical way as baseline
high-dose adenosine group). As
or the baseline study, blood was
rawn before the start of the
denosine infusion to measure
affeine concentration.
The electrocardiographic rhythm
as monitored throughout each
tress procedure, and blood pres-
ure and heart rate recorded ev-
ry 2 min. Symptoms were re-
orded as reported by the patient,
ho was also questioned directly about symptoms every 2
in until completion of the test. Patient symptoms were
raded at the time of test using a symptom-severity score
rom 0 (none) to 3 (severe). A summed score was obtained
y addition of the score for each symptom. Safety was
ssessed by collection of vital signs, electrocardiographic
ata, and adverse events during each procedure. Detailed
nformation on daily caffeine consumption, smoking habit,
edications, and co-morbidities including history of he-
atic or renal disease was collected by a questionnaire.
ietary caffeine intake was estimated according to previ-
usly published data (10,11).
affeine administration. Coffee was prepared on-site us-
ng a 15-bar pump pressure espresso machine. Patients were
iven 2 large shots of espresso, which, according to previous
eports, would provide 200 mg of caffeine (10), the total
affeine content in 2 standard cups of coffee or in a 355-ml
12-fl oz) serving of brewed coffee from specialty shops (10).
he dosage was chosen to reach a serum caffeine concen-
ration 2 mg/l, which is known to inhibit the hemody-
amic response to intravenous adenosine (12).
erum caffeine. Blood samples were taken from a vein
annula, and total serum concentration of caffeine (protein
ound and unbound) was measured by a commercially
vailable homogenous enzyme immunoassay technique
Emit Assay, Dade Behring Ltd., Milton Keynes, United
ingdom).
mage processing. For the baseline procedure, 80 to 120
Bq (2.2 to 3.2 mCi) of thallium-201 was injected 3 min
nto the adenosine infusion and stress image acquisition
tarted within 10 min of thallium-201 injection. Rest
mages were acquired 3 to 4 h later after an additional
njection of 40 MBq (1.1 mCi) of thallium-201. For the
epeat MPS procedure, stress images were acquired in an
dentical way as for baseline. Rest imaging was not con-
ucted to minimize radiation exposure to the patient.
mission tomographic imaging was performed using a
ual-headed gamma camera (Optima, IGE Medical Sys-
ems, Milwaukee, Wisconsin) equipped with a low-energy
ll-purpose collimator. Patients were supine, and 64 projec-
Abbreviations
and Acronyms
CAD  coronary artery
disease
MI  myocardial infarction
MPS  myocardial
perfusion scintigraphy
SDS  summed difference
score
SSS  summed stress
score
TID  transient ischemic
dilationions were acquired over a semicircular 180° arc from 45°
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High-Dose Adenosine Overcomes Caffeine Antagonism December 9, 2008:2008–16ight anterior oblique to 45° left posterior oblique. A 20%
ymmetrical energy window was used at 72 and 167 keV.
ransverse tomograms of the left ventricle were recon-
tructed using a Hanning pre-filter with a cutoff frequency
f 0.75 cycles/cm and a ramp filter during back-projection.
ransaxial slices were reoriented according to current rec-
mmendations (13). No attenuation correction was applied.
mage interpretation. Unprocessed planar images were
isplayed in the cine format to assess quality and to exclude
ignificant patient motion or attenuation. The tomographic
lices were divided into 17 segments, and tracer uptake was
raded semiquantitatively for each segment by 2 experi-
nced nuclear cardiologists without knowledge of clinical
ata or caffeine status. In case of disagreement, the segment
as assigned to a category by a third reader. Scores were
ttributed on a 5-point system by taking into account the
everity of the perfusion defect: 0  normal uptake (tracer
ctivity 70% of maximal myocardial activity); 1  mild
eduction (50% to 69%); 2  moderate reduction (30% to
9%); 3  severe reduction (10% to 29%); and 4  absent
ptake (tracer activity 0% to 9% of maximum). For each
atient, the summed stress score (SSS) and summed rest
core (SRS) were obtained by addition of the perfusion score
or each segment. The summed difference score (SDS) was
stimated by subtracting the SSS from the SRS, and this
easure was used to define the extent and depth of
eversibility.
Each myocardial segment was classified further as show-
ng a fixed, reversible, or partially reversible (mixed) defect,
r as normal. Segments were also assigned to 1 of the
ollowing territories: left anterior descending artery (seg-
ents 1, 2, 7, 8, 13, 14, and 17), left circumflex artery
segments 5, 6, 11, 12, and 16), and right coronary artery
segments 3, 4, 9, 10, and 15) (13). Each territory was
haracterized using the same segmental classification. De-
ect size was quantified as a percentage of the myocardium
nvolved in the left anterior descending, left circumflex, or
ight coronary artery territory. Quantitative defect size,
ransient ischemic dilation (TID [stress/rest left ventricular
olumes ratio 1.22]) and lung thallium-201 uptake (lung/
eart counts ratio 0.45) were calculated using a commer-
ially available program (Quantitative Perfusion SPECT
single-positron emission computed tomography], Cedars-
inai Medical Center, Los Angeles, California).
tatistical analysis. Results were summarized as mean ( SD)
r median (interquartile range). Histogram plots and the
hapiro-Wilk W test were used to test for normality. When
his was the case, comparisons within the groups were
erformed using the t test for paired observations. Non-
ormally distributed data were analyzed using the Wilcoxon
igned-rank test. Comparison between groups was performed
ith the 2-sample t test. Categorical differences were examined
ith the chi-square test or with the McNemar test for paired
bservations. Pearson correlation was used to assess the
ariation in SDS according to serum caffeine concentration. sThe primary outcome measures were SDS and segmental
efect classification at baseline and after caffeine intake. A
eduction in baseline SDS of at least 40% after caffeine was
onsidered to be clinically relevant. A sample of 12 patients
ives 90% power to detect such difference (2-sided signifi-
ance at alpha  0.05). Agreement for segmental defect
lassification between baseline and caffeine studies was
xamined to determine whether high-dose adenosine would
rovoke the same defect in the presence of caffeine com-
ared with the defect at baseline. Because agreement is
ikely to be better than that expected by chance, the value in
he null hypothesis was set at 0.40. A total of 308 myocar-
ial segments gives 90% power to detect a kappa value of
.70 (2-sided significance at alpha  0.05), which is
ndicative of good agreement (14). Differences were consid-
red statistically significant at p values 0.05 (2-sided).
nalysis was performed using SPSS version 14.0 (SPSS
nc., Chicago, Illinois).
esults
atient characteristics. Patient characteristics are summa-
ized in Table 1. Both adenosine MPS procedures were
ompleted at a median interval of 12 days (range 6 to 21
ays). All patients were habitual caffeine consumers with a
edian daily consumption of 5 cups (range 1 to 10 cups) of
ea or coffee, or both, which represents a median caffeine
ntake of 300 mg/day (range 60 to 600 mg/day). None of
he patients had a history of hepatic or renal impairment.
erum caffeine concentration. At baseline, caffeine was
ndetectable in 17 patients (serum caffeine concentration
0.1 mg/l) and ranged from 0.2 to 1.3 mg/l in 13 patients
fter abstention from caffeinated products for a median 18 h
range 12 to 41 h) (Table 2). Sixty minutes after ingestion
f coffee, serum caffeine concentration increased signifi-
antly (Fig. 1).
aseline. At baseline, adenosine stress provoked a sig-
ificant increase in heart rate and rate pressure product in
oth the standard and high-dose adenosine groups,
hereas there was no change in systolic or diastolic blood
ressure (Table 3). There was no difference between
roups for any of the hemodynamic measures (p  0.05
or all comparisons).
affeine. Resting heart rate, blood pressure, and rate pressure
roduct did not change significantly after caffeine intake (Table
). Similarly, caffeine had no effect on the hemodynamic
esponse to either standard or high-dose adenosine. No
tatistically significant difference was found between
roups for any of the hemodynamic parameters (p  0.05
or all comparisons).
ffect of Caffeine on Adenosine MPS
tandard adenosine. Mean SDS decreased by 65% (95%
I: 58% to 73%) after caffeine intake (12.0 4.4 at baseline
s. 4.1  2.1 after caffeine, p  0.001). Individual SDS is
hown in Figure 2. The mean difference in SSS and SDS
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December 9, 2008:2008–16 High-Dose Adenosine Overcomes Caffeine Antagonismetween baseline and caffeine studies was 7.9  3.0 and
7.8  3.2, respectively (Fig. 3). Representative images are
hown in Figure 4.
The number of fully or partially reversible myocardial
egments detected per patient decreased significantly from
.1 1.8 at baseline to 3.7 1.6 after caffeine intake (mean
ifference: 3.4, 95% CI: 2.4 to 4.5, p  0.001). In addition,
uantitative analysis showed a significant reduction in the
edian size of perfusion defect from 18% (3% to 38%) at
aseline to 8% (0% to 22%) after caffeine (p  0.01), with
patients demonstrating a multivessel disease distribution
t baseline compared with 2 patients after caffeine intake
p  0.02).
No statistically significant relationship was found be-
ween SDS changes from baseline to the caffeine study and
erum caffeine concentration (r  0.26, p  0.4). With
egard to nonperfusion markers of ischemia, TID was
bserved in 2 patients and increased thallium-201 lung
Patient Characteristics by Stress Protocol
Table 1 Patient Characteristics by Stress P
All Patients
n 30
Age, yrs 65 7
Weight, kg 82 23
Body mass index, kg/m2 28 3
Hypertension, n (%) 15 (50)
Hypercholesterolemia, n (%) 20 (67)
Smoking, n (%) 12 (40)
Diabetes mellitus, n (%) 10 (33)
Symptoms, n (%)
Chest pain 25 (83)
Exertional dyspnea 21 (70)
Known CAD, n (%) 24 (80)
Previous MI, n (%) 14 (47)
Previous revascularization, n (%)
PCI 10 (33)
CABG 10 (33)
Medication, n (%)
Beta-blocker 20 (67)
Calcium antagonist 8 (27)
Nitrates 6 (20)
Nicorandil 9 (30)
Aspirin 24 (80)
Statin 19 (63)
Values are mean  SD where appropriate.
CABG  coronary artery bypass grafting; CAD  coronary artery dise
Serum Caffeine Concentration
Table 2 Serum Caffeine Concentration
Standard Adeno
(n  12)
Baseline, mg/l 0.2 0.3 (0.0 to 0
Caffeine, mg/l 6.2 2.6 (3.9 to 1
Difference between caffeine
and baseline, mg/l
5.9 2.7 (3.2 toData presented as mean  SD (range). *p  0.01 versus baseline.ptake in 1 patient at baseline but not after coffee ingestion
Fig. 4).
igh-dose adenosine. In contrast to the standard adeno-
ine group, mean SDS did not change significantly after
affeine intake in the high-dose group (7.7 4.0 at baseline
s. 7.8  4.2 after caffeine, p  0.7) (Fig. 2). The mean
ifference in SSS and SDS between baseline and caffeine
tudies was 0.2 2.3 and 0.1 2.4, respectively, which was
ignificantly smaller than the mean difference in SSS and
DS observed with standard adenosine (p  0.001 in both
ases) (Fig. 3).
There was no significant difference in the number of
bnormal myocardial segments detected per patient at
aseline and after caffeine intake (6.8  2.9 vs. 6.7  2.5,
 0.8). The number of fully or partially reversible
egments was also similar (6.0  2.4 at baseline vs. 5.4 
.2 after caffeine, p  0.6). On a segmental basis, overall
greement for defect category between baseline and caffeine
ol
Standard
Adenosine
High-Dose
Adenosine p Value
12 18 —
66 6 64 7 0.4
83 32 81 14 0.8
29 4 27 3 0.1
8 (67) 7 (39) 0.1
7 (58) 13 (72) 0.4
4 (33) 8 (44) 0.7
6 (50) 4 (22) 0.1
10 (83) 15 (83) 0.9
10 (83) 11 (61) 0.2
9 (75) 15 (83) 0.5
4 (33) 10 (56) 0.2
5 (42) 5 (28) 0.4
3 (25) 7 (39) 0.4
7 (58) 13 (72) 0.4
3 (25) 5 (28) 0.8
3 (25) 3 (17) 0.5
4 (33) 5 (28) 0.7
10 (83) 14 (78) 0.7
7 (58) 12 (67) 0.6
I  myocardial infarction; PCI  percutaneous coronary intervention.
High-Dose Adenosine
(n  18) p Value
0.3 0.4 (0.0 to 1.3) 0.2
5.7 2.0 (2.9 to 9.6)* 0.5
3) 5.4 2.1 (2.0 to9.3) 0.3rotocsine
.8)
2.3)*
12.
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High-Dose Adenosine Overcomes Caffeine Antagonism December 9, 2008:2008–16tudies was 84% (258 of 306 segments, kappa  0.72, 95%
I: 0.65 to 0.79) (Table 4). On a vascular territory basis,
greement for defect category was 87% (47 of 54 territories,
appa  0.81, 95% CI: 0.69 to 0.93). Regarding nonper-
usion markers of ischemia, TID was present in 2 patients
oth at baseline and after caffeine intake. A case example is
hown in Figure 5.
ide effects. At baseline, 26 of 30 (87%) patients experi-
nced side effects during adenosine stress testing (Table 5).
f 47 side effects, 44 (94%) were graded as mild. None of
he side effects was graded as severe. After caffeine intake,
he total occurrence of side effects decreased by 71% in the
tandard adenosine group. The summed symptom score also
ecreased from 1.6  1.1 at baseline to 0.6  0.7 after
affeine (p  0.02). In contrast, the frequency of side effects
Figure 1 Serum Caffeine After Coffee Ingestion
Distribution of serum caffeine concentrations across
the study population after coffee consumption (n  30).
Hemodynamic Response to Adenosine Stress
Table 3 Hemodynamic Response to Adenos
Standard Adeno
Baseline
140 g/kg/min*
Rest
HR, beats/min 65 12
SBP, mm Hg 146 18
DBP, mm Hg 83 10
RPP, 103 mm Hg · min1 9.5 1.9
Stress
HR, beats/min 91 17†
SBP, mm Hg 152 20
DBP, mm Hg 83 11
RPP, 103 mm Hg · min1 13.8 3.2†
Peak watts, median (range)‡ 75 (15 to 75)
Values are mean  SD unless indicated otherwise. *Adenosine dose.
isometric exercise with handgrip.
DBP  diastolic blood pressure; HR  heart rate; RPP  rate-pressure prot baseline and after caffeine was similar in the high-dose
roup (Table 5). The summed symptom score was also
imilar (1.4  1.1 at baseline vs. 1.3  1.2 after caffeine,
 0.9). There were no electrocardiographic changes
ttributable to either caffeine intake or a high dose of
denosine. No adverse events occurred, and no patient
eeded aminophylline, dose reduction, or early termination
f the adenosine infusion either at baseline or after caffeine.
iscussion
he present study is the first to demonstrate that caffeine in
offee attenuates the magnitude of myocardial perfusion
bnormality elicited by adenosine stress testing. According
o the study, intake of caffeine before stress may result in
ignificant underestimation of the extent of flow-limiting
oronary disease by adenosine MPS, which has important
mplications for patient management. This observation
trengthens the hypothesis that caffeine is an effective
ntagonist at the coronary adenosine receptors. The study
lso shows for the first time that the inhibitory effect of
affeine on adenosine-induced hyperemia can be sur-
ounted by increasing the adenosine dose. These results all
ogether provide further evidence of the competitive inter-
ction between adenosine and caffeine and its potential
mpact on the efficacy of vasodilator stress.
Caffeine is the most widely consumed psychoactive drug,
ith a per capita consumption estimated at 280 mg/day in
he U.S. and as high as 400 mg/day in the Scandinavian
ountries and in the United Kingdom (15). Coffee is the
ain source of caffeine worldwide. Caffeine content in a
egular cup of coffee varies greatly depending on the variety
f coffee bean and brewing method used (10,16), and thus
aution must be exercised when relating the physiological
ffects of caffeine to coffee intake rather than to actual
affeine concentrations. In addition, caffeine levels in plasma
fter coffee ingestion can vary widely owing to interindi-
idual differences in caffeine metabolism (9,17), which is the
tress
 12) High-Dose Adenosine (n  18)
Caffeine
g/kg/min
Baseline
140 g/kg/min
Caffeine
210 g/kg/min
65 13 63 9 65 10
41 16 143 18 144 19
86 8 83 12 84 11
.2 2.0 9.1 1.9 9.3 2.2
88 17† 94 14† 97 12†
52 16 149 18 143 20
87 12 82 14 79 11
.3 2.5† 14.0 2.5† 13.8 2.7†
(15 to 75) 75 (25 to 75) 75 (25 to 75)
.01 versus rest values. ‡Patients unable to cycle (n  2) performedine S
sine (n
140
1
9
1
13
75
†p  0duct; SBP  systolic blood pressure.
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December 9, 2008:2008–16 High-Dose Adenosine Overcomes Caffeine Antagonismost likely explanation for the observed variability in serum
affeine concentrations despite standard brewing of the
ame coffee brand.
In line with recent observations (18), coffee ingestion had
o effect on resting blood pressure or heart rate, probably
ecause of caffeine habituation and development of toler-
nce (19). As indicated in previous experimental studies
20,21), our results suggest that caffeine habituation does not
odify the potency of caffeine at the adenosine receptors.
The primary mechanism of action of caffeine in humans
ccurs through the blockade of adenosine receptors (2,22).
lthough caffeine interacts with the receptors at low con-
entrations (2,3), it is relatively less potent than other
anthines at the A2A subtype, which is responsible for the
oronary vasodilator effect of adenosine (2). Indeed, caffeine
ad no effect on myocardial blood flow heterogeneity
nduced by intravenous adenosine at plasma concentrations
Figure 2 SDS at Baseline and After Caffeine
Individual and mean (95% confidence interval) summed difference score (SDS) at
after caffeine intake during (A) standard and (B) high-dose adenosine myocardial
Figure 3 Mean Difference in SSS and SDS Between Baseline a
Mean difference in (A) summed stress scores (SSS) and (B) summed difference s
caffeine myocardial perfusion scintigraphy studies for the standard and high-dosehat were almost one-half the concentrations attained in the
resent study (7). Similar concentrations of caffeine did not
odify the hyperemic response to intracoronary adenosine
s measured by the fractional flow reserve in patients with
ngiographically significant coronary artery stenosis (8).
lso, comparable caffeine levels do not appear to attenuate
he peak hyperemic effect of selective A2A adenosine recep-
or agonism (23).
By contrast, administration of a high dose of caffeine was
ffective at inhibiting selective A2A-receptor–mediated cor-
nary vasodilation in a canine model (24). The results of the
resent study extend this observation to the clinical setting
nd support the notion that at a dose commonly encoun-
ered in daily life, caffeine blocks the coronary A2A receptors
rom adenosine, thereby attenuating its vasodilator action
nd potentially reducing the sensitivity of adenosine MPS
or the detection of coronary stenosis. Caffeine also reduced
e and
ion scintigraphy.
ffeine Studies
(SDS) between baseline and
sine groups. Error bars represent  SEM.baselin
perfusnd Ca
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High-Dose Adenosine Overcomes Caffeine Antagonism December 9, 2008:2008–16he frequency and severity of adenosine-related side effects,
eflecting its nonselective action at the various adenosine
eceptors (2,3). The lack of a concentration-response effect
f serum caffeine levels on the reversibility of perfusion
bnormality in the present study was most likely the result
f insufficient statistical power to detect such an effect.
The current study also demonstrates that, in the presence
f inhibitory concentrations of caffeine, administration of
10 g/kg/min of adenosine elicits myocardial perfusion
bnormality similar to that of unantagonized adenosine.
Figure 4 MPS Images of Same Patient Illustrating Effect of Ca
The baseline myocardial perfusion scintigraphy (MPS) images of a patient with a h
sion abnormalities associated with transient ischemic dilation and increased right ven
mg/l), there is marked reduction in the magnitude of perfusion abnormalities. TID and
SA  short-axis view; VLA  vertical long-axis view.
egmental Agreement Between Baseline and Caffeinetudies in the High-Dose Ad nosine Group Accordingo Type of Perfusion Abnormality (n  18)
Table 4
Segmental Agreement Between Baseline and Caffeine
Studies in the High-Dose Adenosine Group According
to Type of Perfusion Abnormality (n  18)
Caffeine, n (%)
Baseline, n (%) Normal Reversible Mixed Fixed
Normal 168 (55) 15 (5) 1 (0) 0 (0)
Reversible 19 (6) 55 (18) 0 (0) 3 (1)
Mixed 0 (0) 1 (0) 20 (7) 4 (1)
Fixed 0 (0) 0 (0) 5 (2) 15 (5)cbserved overall agreement 84% (258 of 306 segments).his finding indicates that an increase in dose restores
oronary responsiveness to adenosine and that, in most
nstances, a 50% increment would be sufficient to surmount
he inhibitory effect of a relatively large intake of caffeine.
mportantly, the use of a high dose of adenosine after coffee
ngestion was well tolerated regardless of serum caffeine
oncentration.
It is not possible to determine from this study whether
he observed changes of inducible perfusion abnormality are
ue to reduction of hyperemic perfusion or to increase in
aseline perfusion. However, previous positron emission
omography studies have shown that caffeine does not
ncrease resting perfusion (6,18); therefore, we can assume
hat caffeine-induced changes are due to a reduction in
denosine-induced hyperemia.
Finally, the study highlights the difficulties in standardizing
he use of adenosine in patients who have consumed caffeine,
nd underscores the importance of screening for caffeine intake
efore adenosine MPS. According to our results, patients who
onsume caffeine within a few hours before the test could be
on Standard Adenosine MPS
of angina show extensive and profound apical and anteroseptal inducible perfu-
thallium-201 uptake in the stress tomograms. After coffee (serum caffeine  12.3
mal right ventricular uptake are no longer present. HLA  horizontal long-axis view;ffeine
istory
tricular
abnoronsidered for high-dose adenosine stress testing.
S
t
a
I
b
r
p
2015JACC Vol. 52, No. 24, 2008 Reyes et al.
December 9, 2008:2008–16 High-Dose Adenosine Overcomes Caffeine Antagonismtudy limitations. A potential limitation of the study is
hat the effect of caffeine on standard and high-dose
denosine was investigated in 2 separate groups of patients.
deally, patients should have undergone both interventions
Figure 5 High-Dose Adenosine MPS After Caffeine in a Patient
The baseline myocardial perfusion scintigraphy (MPS) images show profound apica
abnormalities. After coffee ingestion (serum caffeine  8.9 mg/l) and high-dose a
Side Effects During Adenosine Stress
Table 5 Side Effects During Adenosine Stres
Standard Adenosine
Side Effects
Baseline
140 g/kg/min* 14
Any symptom 10 (83)
Chest pain 8 (67)
Dyspnea 6 (50)
Flushing 5 (42)
Headache 1 (8)
Dizziness 1 (8)
Abdominal discomfort 0
Other 1 (8)
Atrioventricular block 0
Ischemic ECG changes† 0
Data presented as n (%). *Adenosine infusion rate. †Horizontal or dow
versus baseline. §p  0.05 versus baseline.ECG  electrocardiogram.ut that would have resulted in an unacceptably high
adiation burden on the patient.
Detailed angiographic data were not available for all
atients, and therefore it was not possible to assess the
Prior Myocardial Infarction and Recurrent Symptoms
roseptal and mild inferoapical and inferoseptal inducible perfusion
ine (210 g/kg/min), the images are unchanged. Abbreviations as in Figure 4.
2) High-Dose Adenosine (n  18)
eine
/kg/min
Baseline
140 g/kg/min
Caffeine
210 g/kg/min
2)‡ 16 (89) 12 (67)
7)§ 8 (44) 7 (39)
3) 7 (39) 8 (44)
8 (44) 8 (44)
1 (6) 0
0 0
0 1 (6)
1 (6) 1 (6)
1 (6) 1 (6)
1 (6) 1 (6)
g ST-segment depression0.1 mV 80 ms after the J point. ‡p 0.06With
l ante
denoss
(n  1
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High-Dose Adenosine Overcomes Caffeine Antagonism December 9, 2008:2008–16mpact of caffeine intake on the diagnostic accuracy of
denosine MPS. Nonetheless, our results strongly suggest
hat moderate coffee ingestion before stress testing would
ignificantly reduce the sensitivity of adenosine MPS for the
etection of coronary stenosis.
We studied the effect of caffeine on adenosine combined
ith exercise rather than on adenosine only. The fact that
denosine stress testing is increasingly performed with
xercise is important, because results of studies on adenosine
nly may not be easily extrapolated to the combined
rotocol. The addition of exercise could have influenced the
esults, although the paired design minimizes the potential
onfounding effect. Exercise might have blunted the periph-
ral effects of caffeine and adenosine, but it is unlikely that
t would have potentiated caffeine antagonism. If anything,
xercise might partly have offset the antagonism in some
atients by eliciting active hyperemia.
Only males were recruited, and therefore our results may
ot be transferable to females. In women, ovarian hormones
nd their synthetic analogues can influence the metabolism
nd gastrointestinal absorption of caffeine, thus potentially
ltering both peak and time to peak levels of caffeine in
lasma (25). This potential confounding factor warrants
urther investigation in female populations.
onclusions
he present study demonstrates the competitive antagonism
etween adenosine and caffeine, and the impact of such
nteraction on myocardial perfusion imaging. Because of the
elatively low affinity of adenosine receptors for caffeine, the
ffect of this xanthine is highly dose dependent. Moderate
offee intake attenuates adenosine-induced vasodilation in a
urmountable manner, and thus an increase in adenosine
ose may represent an alternative approach to the manage-
ent of patients who consume caffeine before adenosine
tress testing. The potential benefit of such an intervention
rovides a rationale to further investigate its feasibility and
afety in routine clinical practice.
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